KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 149 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,925 | +46.8% | 2,929 | +96.1% | 0.00% | 0.0% |
Q2 2023 | $2,674 | -55.2% | 1,494 | -2.7% | 0.00% | -50.0% |
Q1 2023 | $5,975 | +113.0% | 1,536 | +86.2% | 0.00% | +100.0% |
Q4 2022 | $2,805 | -29.9% | 825 | +10.4% | 0.00% | -50.0% |
Q3 2022 | $4,000 | – | 747 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |